Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Oct 9.
Published in final edited form as: Biol Med (Aligarh). 2014;6(1):1000198. doi: 10.4172/1234-3425.1000198

GABAA Receptor Expression in the Forebrain of Ataxic Rolling Nagoya Mice

Elsebet Østergaard Nielsen 1, Simon Kaja 1,2,3,4,*
PMCID: PMC4191822  NIHMSID: NIHMS630477  PMID: 25309056

Abstract

The human CACNA1A gene encodes the pore-forming α1 subunit of CaV2.1 (P/Q-type) calcium channels and is the locus for several neurological disorders, including episodic ataxia type 2 (EA2), spinocerebellar ataxia type 6 (SCA6) and Familial Hemiplegic Migraine type 1 (FHM1). Several spontaneous mouse Cacna1a mutant strains exist, among them Rolling Nagoya (tgrol), carrying the R1262G point mutation in the mouse Cacna1a gene. tgrol mice display a phenotype of severe gait ataxia and motor dysfunction of the hind limbs. At the functional level, the R1262G mutation results in a positive shift of the activation voltage of the CaV2.1 channel and reduced current density. γ-Aminobutyric acid type A (GABAA) receptor subunit expression depends critically on neuronal calcium influx, and GABAA receptor dysfunction has previously been described for the cerebellum of tgrol and other ataxic Cacna1a mutant mice. Given the expression pattern of CaV2.1, it was hypothesized that calcium dysregulation in tgrol might affect GABAA receptor expression in the forebrain. Herein, functional GABAA receptors in the forebrain of tgrol mice were quantified and pharmacologically dissociated using [3H] radioligand binding. No gross changes to functional GABAA receptors were identified. Future cell type-specific analyses are required to identify possible cortical contributions to the psychomotor phenotype of tgrol mice.

Keywords: Gamma aminobutyric receptor type A, Calcium, Ataxia, Pharmacology, Motor dysfunction, Rolling Nagoya, Cacan1a, CaV2.1, P/Q-type calcium channel

Introduction

The human CACNA1A gene encodes the α1 subunit of neuronal voltage-gated CaV2.1 (P/Q-type) calcium channels. Furthermore, CACNA1A is the locus of several genetic neurological diseases, including Episodic Ataxia type 2 (EA2), spinocerebellar ataxia type 6 (SCA6), familial hemiplegic migraine type 1 (FHM1) and rare forms of epilepsy [14].

Multiple mouse strains exist that carry mutations in the orthologous mouse Cacna1a gene, including Rolling Nagoya (tgrol), Tottering (tg) and Leaner (tgla); these strains arose spontaneously and exhibit phenotypes of cerebellar ataxia often paired with absence epilepsy and/or other motor phenotypes such as dyskinesia and dystonia [57]. Furthermore, transgenic knock-in (KI) mouse models have been generated to harbor the human FHM1 missense mutations R192Q and S218L in the Cacna1a gene [8,9].

The tgrol mouse carries the R1262G mutation that results in a phenotype of pure cerebellar ataxia [6,10]. At the functional level, the mutation results in a loss-of-function phenotype withCaV2.1 channels exhibiting a positive shift of the activation voltage and reduced current density both in recombinant expression systems and primary culture cerebellar Purkinje cells from tgrol mice [11]. A similar loss-of-function synaptic phenotype was reported for the neuromuscular junction [12].

Numerous studies have investigated anatomy and morphology of the tgrol brain and expression and distribution of neurotransmitter receptors in the tgrol nervous system [10]. However, there is still a controversy regarding the presence and/or extent of cerebellar morphological abnormalities as well as the contribution of striatal dysfunction to the ataxic phenotype of tgrol [13,14].

The rationale for the present study is based on the functional link between neuronal Ca2+ influx and GABAA receptor subunit expression [1519]. In the cerebellum, the loss of GABAergic inhibition may decrease tonic inhibition in cerebellar granule cells (CGCs), leading to ataxia in Angelman syndrome [20]. Similarly, an aberrant GABAAR complement may contribute to the ataxic phenotype of tg, tgla and tgrol mice [2123].

Given the abundant expression of CaV2.1 channels in the cerebrum, it was hypothesized that functional GABAA receptor subunit expression may be altered in the forebrain of tgrol mice. Functional GABAA receptors in the forebrain of tgrol were subsequently quantified and pharmacologically dissociated using [3H] radioligand binding.

Materials and Methods

Tissue

Tissue from Rolling Nagoya mice was kindly provided by Drs. Jaap Plomp and Arn van den Maagdenberg (Leiden University Medical Center, Leiden, The Netherlands).

[3H] Radioligand binding assays

[3H] Radioligand binding was essentially performed as described previously [23]. Mice were euthanized by cervical dislocation and forebrain (without olfactory bulb) and cerebellum were dissected into 0.1 M ice-cold phosphate buffered saline (pH 7. r [3H] muscimol binding, 50 mM Tr 4) and snap frozen in liquid nitrogen. Tissue was thawed on ice in 50 volumes assay buffer (50 mM Tris-citrate pH 7.3 for [3H] muscimol binding, 50 mM Tris-HCl pH 7.4 for [3H] Ro15-4513 and [3H] Ro15-1788 binding). Samples were homogenized in a Dounce tissue grinder and centrifuged at 750×g for 10 min at 4°C. Supernatants were subsequently centrifuged at 45,000Xg for 30 min, the pellet was washed in 50 volumes assay buffer and re-homogenized. In order to release endogenous neurotransmitter, tissue was incubated for 30 min in 37°C water bath and re-centrifuged. The pellet was then resuspended in 50 volumes assay buffer, flash frozen in liquid nitrogen and stored overnight at −20°C. Immediately prior to experiments, tissue was thawed in a waterbath at ambient temperature, centrifuged and the pellet resuspended 200-fold for [3H] muscimol experiments and 500-fold for [3H] R015-4513 and [3H] Ro15-1788 binding. Protein concentrations of membrane preparations were determined by the method of Lowry [24] employing bovine serum albumin as the standard protein for calibration.

Data analysis and statistics

Data throughout this manuscript is presented as mean ± s.e.m. Data was analyzed in SigmaPlot v10 (Systat Software, Inc., San Jose, CA) using the one-binding site regression tool with 200 iterations. Overall Bmax and KD values were obtained by calculating the mean values obtained from each individual animal. Rosenthal transformations were performed on radioligand binding data and plotted as Scatchard plots for illustration purposes only [23,25,26]. Statistically significant differences were tested for using Student’s t-tests, as appropriate. Statistical significance was defined as P<0.05.

Results

[3H] Muscimol binding

In order to determine the total number of functional GABA binding sites expressed on forebrain membranes, [3H] muscimol binding was performed. Fitting the binding curve using a single binding-site equation revealed no statistically significant difference between the Bmax of wt and tgrol mice (n=4, P=0.70) (Figures 1A and C). Rosenthal transformations of the data are presented as Scatchard plot for illustration (Figure 1B). The KD values for [3H] muscimol binding were similar between genotypes (n=4, P=0.73) (Figure 1D).

Figure 1.

Figure 1

[3H] Muscimol binding.

(A) [3H] Muscimol binding to wt and tgrol forebrain membrane homogenates was similar when fitted to a one-site binding curve. (B) Rosenthal transformation was carried out and the Scatchard plot is shown. (C) Bmax values were not statistically significant different between wt and tgrol. Individual values were obtained from fitting a binding curve against the forebrain sample of a single animal. (D) Similarly, no differences in KD value were obtained.

[3H] Ro15-4513 and [3H] flumazenil binding

Next, benzodiazepine receptor binding, identifying γ2 subunit-containing GABAA receptors, was quantified using [3H] Ro15-4513 and [3H] flumazenil. Total [3H] Ro15-4513 binding was similar between wt and tgrol forebrain membranes (n=4, P=0.56) (Figures 2A–C). Binding affinity, expressed as KD, was not statistically significantly different between genotypes (n=4, P=0.10) (Figure 2D). In order to address the possibility of subunit changes, benzodiazepine-insensitive (BZ-IS) and benzodiazepine-sensitive (BZ-S) binding sites were differentiated pharmacologically (Figures 2E–H). BZ-IS binding was quantified in the presence of 10 μM flunitrazepam (Figure 2E). Bmax and KD values did not differ between wt and tgrol (n=4, P=0.92) (Figures 2G and H). Subsequently, BZ-S binding could be calculated mathematically by subtracting BZ-IS binding from total binding (Figure 2F).

Figure 2.

Figure 2

[3H] Ro15-4513 binding.

(A) Total [3H] Ro15-4513 binding was not affected by the tgrol mutation in Cacna1a. (B) Rosenthal transformation was carried out and the Scatchard plot is shown. (C) Bmax values did not differ between wt and tgrol. (D) Similarly, KD values were similar between wt and tgrol. (E) [3H] Ro15-4513 binding in the presence of 10 μM flunitrazepam defined BZ-IS binding sites did not differ between genotypes. (F) BZ-S [3H] Ro15-4513 binding was determined by subtraction of the estimated number of BZ-IS binding sites from total [3H] Ro15-4513 specific binding sites were similar between wt and tgrol mice. (G–H) Bmax and KD values did not differ between wt and tgrol mice.

Lastly, [3H] flumazenil (Ro15-1788) binding to forebrain membranes was quantified. No differences in Bmax (n=4, P=0.95) and KD (n=4, p=0.20) were identified (Figures 3A–D).

Figure 3.

Figure 3

[3H] Flumazenil (Ro15-1788) binding.

(A) [3H] Flumazenil binding did not reveal any quantitative differences between binding to wt and tgrol forebrain membrane homogenates. (B) Scatchard plot is shown for illustration. (C–D) Bmax and KD values did not differ between wt and tgrol mice.

Discussion

In this study, GABAA receptor binding sites in the cerebrum of wt and tgrol mice were quantified by [3H] ligand binding. We utilized highly selective, well-established GABAA receptor ligands to investigate GABAA receptor pharmacology in forebrain membranes of the Cacna1a mutant tgrol and wt littermate control. In rapid filtration assays, muscimol recognizes all GABAARs. In forebrain membranes, the major GABAA receptor comprises α1β2γ2 subunit, accounting for approximately 50% of all GABAA receptors [27,28]. [3H] Ro15-4513 and [3H] flumazenil (Ro15-1788) were used as ligands for the benzodiazepine binding site of GABAARs and to identify γ2 subunit-containing receptors [29,30]. Specificity of ligands was confirmed by using 10-fold excess concentrations of unlabeled ligands to displace [3H] ligands (data not shown), as described previously [23]. Rapid filtration assays did not reveal any differences between the number and pharmacology of functional GABAA receptors in forebrain membranes of wt and tgrol mice. The Bmax and KD values obtained for GABAA receptor binding were similar to those reported previously [31,32]. At the molecular level, the tgrol mutation (R12642) is located in the domain III voltage-sensor region of the CaV2.1 protein and results in a positive shift of the activation voltage of the channel and overall reduced current density of the P/Q-type current [11], thought to result in impaired neurotransmission and transmitter secretion [10,12]. CaV2.1 channels are distributed widely throughout the mammalian central nervous system [33]. The rationale for this study was derived from the regulation of GABAA receptor subunits by Ca2+ influx [1519] and that striatal dysfunction contributing to ataxia may result from GABAergic changes in the forebrain.

There could be several reasons for the absence of GABAA receptor abnormalities in the forebrain in the presence of the tgrol mutation: 1) Compensatory Ca2+ channel expression may restore intracellular Ca2+ signaling leading to normal Ca2+ influx. Unfortunately, there is no data available to date to support or reject this hypothesis. At the neuromuscular junction, where CaV2.1 channels are the exclusive mediators of acetylcholine release, no compensatory Ca2+ channel expression was found [23]. 2) Region and/or cell type-specific changes may be occluded when quantifying binding to membrane preparations. Future studies employing autoradiography are needed to confirm our results presented herein. 3) Effects of Cacna1a mutations are dependent critically on the specific splice isoform of the CaV2.1 channel. For instance, FHM1 mutations in Cacna1a exhibit greater hyperpolarizing shifts in voltage-dependence when expressed in the short (CaV2.1Δ47) versus the long C-terminal variant (CaV2.1+47) [34]. Cerebellar splice variants may be more susceptible to the effects of the tgrol mutation and results in disruption of Ca2+ signaling and thus cause the ensuing cerebellar GABAA receptor dysfunction in tgrol mice [21].

In conclusion, we did not identify any gross changes in GABAA receptor pharmacology and expression in the forebrain of tgrol mice. Future cell type-specific analyses are required to confirm cortical contributions to the psychomotor phenotype of tgrol mice.

Acknowledgments

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number GM102631. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to thank Dr. Jaap Plomp (Leiden University Medical Center, Leiden, The Netherlands) for sharing his expertise on Rolling Nagoya mice and calcium channel biophysics. This work is dedicated to the memory of the late Christopher L. Thompson, Ph.D. (1960–2007), a passionate scientist, inspiring mentor and wonderful friend, who introduced the senior author to the field of GABAA receptors.

References

  • 1.Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543–552. doi: 10.1016/s0092-8674(00)81373-2. [DOI] [PubMed] [Google Scholar]
  • 2.Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet. 1997;15:62–69. doi: 10.1038/ng0197-62. [DOI] [PubMed] [Google Scholar]
  • 3.Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet. 2001;358:801–807. doi: 10.1016/S0140-6736(01)05971-2. [DOI] [PubMed] [Google Scholar]
  • 4.Imbrici P, Jaffe SL, Eunson LH, Davies NP, Herd C, et al. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain. 2004;127:2682–2692. doi: 10.1093/brain/awh301. [DOI] [PubMed] [Google Scholar]
  • 5.GREEN MC, SIDMAN RL. Tottering–a neuromusclar mutation in the mouse. And its linkage with oligosyndacylism. J Hered. 1962;53:233–237. doi: 10.1093/oxfordjournals.jhered.a107180. [DOI] [PubMed] [Google Scholar]
  • 6.Oda S. The observation of rolling mouse Nagoya (rol), a new neurological mutant, and its maintenance (author’s transl) Jikken Dobutsu. 1973;22:281–288. doi: 10.1538/expanim1957.22.4_281. [DOI] [PubMed] [Google Scholar]
  • 7.Herrup K, Wilczynski SL. Cerebellar cell degeneration in the leaner mutant mouse. Neuroscience. 1982;7:2185–2196. doi: 10.1016/0306-4522(82)90129-4. [DOI] [PubMed] [Google Scholar]
  • 8.van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004;41:701–710. doi: 10.1016/s0896-6273(04)00085-6. [DOI] [PubMed] [Google Scholar]
  • 9.van den Maagdenberg AM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol. 2010;67:85–98. doi: 10.1002/ana.21815. [DOI] [PubMed] [Google Scholar]
  • 10.Plomp JJ, van den Maagdenberg AM, Kaja S. The ataxic Cacna1a-mutant mouse Rolling Nagoya: an overview of neuromorphological and electrophysiological findings. Cerebellum. 2009;8:222–230. doi: 10.1007/s12311-009-0117-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mori Y, Wakamori M, Oda S, Fletcher CF, Sekiguchi N, et al. Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation Rolling Nagoya (tg(rol)) J Neurosci. 2000;20:5654–5662. doi: 10.1523/JNEUROSCI.20-15-05654.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Kaja S, van de Ven RC, van Dijk JG, Verschuuren JJ, Arahata K, et al. Severely impaired neuromuscular synaptic transmission causes muscle weakness in the Cacna1a-mutant mouse Rolling Nagoya. EurJNeurosci. 2007b;25:2009–2020. doi: 10.1111/j.1460-9568.2007.05438.x. [DOI] [PubMed] [Google Scholar]
  • 13.Kato M, Hosokawa S, Tobimatsu S, Kuroiwa Y. Increased local cerebral glucose utilization in the basal ganglia of the rolling mouse Nagoya. J Cereb Blood Flow Metab. 1982;2:385–393. doi: 10.1038/jcbfm.1982.44. [DOI] [PubMed] [Google Scholar]
  • 14.Tomoda H, Kato M, Sakata S, Shima F. Striatal dysfunction in Rolling mouse Nagoya: an electrophysiological study. J Neurol Sci. 1992;112:106–112. doi: 10.1016/0022-510x(92)90139-c. [DOI] [PubMed] [Google Scholar]
  • 15.Hansen GH, Belhage B, Schousboe A. First direct electron microscopic visualization of a tight spatial coupling between GABAA-receptors and voltage-sensitive calcium channels. Neurosci Lett. 1992;137:14–18. doi: 10.1016/0304-3940(92)90287-h. [DOI] [PubMed] [Google Scholar]
  • 16.Gault LM, Siegel RE. Expression of the GABAA receptor delta subunit is selectively modulated by depolarization in cultured rat cerebellar granule neurons. J Neurosci. 1997;17:2391–2399. doi: 10.1523/JNEUROSCI.17-07-02391.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gault LM, Siegel RE. NMDA receptor stimulation selectively initiates GABA(A) receptor delta subunit mRNA expression in cultured rat cerebellar granule neurons. J Neurochem. 1998;70:1907–1915. doi: 10.1046/j.1471-4159.1998.70051907.x. [DOI] [PubMed] [Google Scholar]
  • 18.Houston CM, Lee HH, Hosie AM, Moss SJ, Smart TG. Identification of the sites for CaMK-II-dependent phosphorylation of GABA(A) receptors. J Biol Chem. 2007;282:17855–17865. doi: 10.1074/jbc.M611533200. [DOI] [PubMed] [Google Scholar]
  • 19.Houston CM, Hosie AM, Smart TG. Distinct regulation of beta2 and beta3 subunit-containing cerebellar synaptic GABAA receptors by calcium/calmodulin-dependent protein kinase II. J Neurosci. 2008;28:7574–7584. doi: 10.1523/JNEUROSCI.5531-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Egawa K, Kitagawa K, Inoue K, Takayama M, Takayama C, et al. Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci Transl Med. 2012;4:163ra157. doi: 10.1126/scitranslmed.3004655. [DOI] [PubMed] [Google Scholar]
  • 21.Yamaguchi T, Hayashi K, Murakami H, Maruyama S, Yamaguchi M. Distribution and characterization of the GABA receptors in the CNS of ataxic mutant mouse. Neurochem Res. 1984;9:485–495. doi: 10.1007/BF00964375. [DOI] [PubMed] [Google Scholar]
  • 22.Ogasawara M, Kurihara T, Hu Q, Tanabe T. Characterization of acute somatosensory pain transmission in P/Q-type Ca(2+) channel mutant mice, leaner. FEBS Lett. 2001;508:181–186. doi: 10.1016/s0014-5793(01)03052-6. [DOI] [PubMed] [Google Scholar]
  • 23.Kaja S, Hann V, Payne HL, Thompson CL. Aberrant cerebellar granule cell-specific GABAA receptor expression in the epileptic and ataxic mouse mutant, Tottering. Neuroscience. 2007;148:115–125. doi: 10.1016/j.neuroscience.2007.03.055. [DOI] [PubMed] [Google Scholar]
  • 24.LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275. [PubMed] [Google Scholar]
  • 25.Thompson CL, Tehrani MH, Barnes EM, Jr, Stephenson FA. Decreased expression of GABAA receptor alpha6 and beta3 subunits in stargazer mutant mice: a possible role for brain-derived neurotrophic factor in the regulation of cerebellar GABAA receptor expression? Brain ResMolBrain Res. 1998;60:282–290. doi: 10.1016/s0169-328x(98)00205-8. [DOI] [PubMed] [Google Scholar]
  • 26.Payne HL, Donoghue PS, Connelly WM, Hinterreiter S, Tiwari P, et al. Aberrant GABA(A) receptor expression in the dentate gyrus of the epileptic mutant mouse stargazer. J Neurosci. 2006;26:8600–8608. doi: 10.1523/JNEUROSCI.1088-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sieghart W, Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem. 2002;2:795–816. doi: 10.2174/1568026023393507. [DOI] [PubMed] [Google Scholar]
  • 28.Heldt SA, Ressler KJ. Forebrain and midbrain distribution of major benzodiazepine-sensitive GABAA receptor subunits in the adult C57 mouse as assessed with in situ hybridization. Neuroscience. 2007;150:370–385. doi: 10.1016/j.neuroscience.2007.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Möhler H, Battersby MK, Richards JG. Benzodiazepine receptor protein identified and visualized in brain tissue by a photoaffinity label. Proc Natl Acad Sci U S A. 1980;77:1666–1670. doi: 10.1073/pnas.77.3.1666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Möhler H, Sieghart W, Richards JG, Hunkeler W. Photoaffinity labeling of benzodiazepine receptors with a partial inverse agonist. Eur J Pharmacol. 1984;102:191–192. doi: 10.1016/0014-2999(84)90358-3. [DOI] [PubMed] [Google Scholar]
  • 31.DeLorey TM, Brown GB. gamma-Aminobutyric acidA receptor pharmacology in rat cerebral cortical synaptoneurosomes. J Neurochem. 1992;58:2162–2169. doi: 10.1111/j.1471-4159.1992.tb10959.x. [DOI] [PubMed] [Google Scholar]
  • 32.Squires RF, Ai J, Witt MR, Kahnberg P, Saederup E, et al. Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites. Neurochem Res. 1999;24:1593–1602. doi: 10.1023/a:1021116502548. [DOI] [PubMed] [Google Scholar]
  • 33.Catterall WA. Voltage-gated calcium channels. Cold Spring Harb Perspect Biol. 2011;3:a003947. doi: 10.1101/cshperspect.a003947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Adams PJ, Garcia E, David LS, Mulatz KJ, Spacey SD, et al. Ca(V)2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies. Channels (Austin) 2009;3:110–121. doi: 10.4161/chan.3.2.7932. [DOI] [PubMed] [Google Scholar]

RESOURCES